Latest information
Latest information
Guangzhou Pharmaceutical Research Institute participates in the symposium and promotion meeting on the construction of the national biological germplasm and experimental material resource library
Our company has been invited to participate in the "Assisting Phase I&BE Clinical Trial Practice Skills and Innovative Development" training course and industry docking meeting, and prov
Youth in a Prosperous Era, Striving at the Right Time - Record of the Welcome Ceremony for New Employees of Guangzhou Pharmaceutical General Hospital in 2019
Guangzhou Pharmaceutical Research Institute participates in the symposium and promotion meeting on the construction of the national biological germplasm and experimental material resource library
2019-08-14
Guangzhou Pharmaceutical Research Institute participates in the symposium and promotion meeting on the construction of the national biological germplasm and experimental material resource library
2019-08-14
Our company has been invited to participate in the "Assisting Phase I&BE Clinical Trial Practice Skills and Innovative Development" training course and industry docking meeting, and prov
2019-08-14
崗位職責(zé):
1、負(fù)責(zé)網(wǎng)絡(luò)及其設(shè)備的維護(hù)、管理、故障排除等日常工作,確保網(wǎng)絡(luò)日常的正常運(yùn)作;
2、解決排除各種軟硬件故障,做好記錄,定期制作系統(tǒng)運(yùn)行報(bào)告;
4、維護(hù)數(shù)據(jù)中心,對(duì)系統(tǒng)數(shù)據(jù)進(jìn)行備份。
負(fù)責(zé)非臨中心計(jì)算系統(tǒng)的管理,包括維護(hù)、運(yùn)行、定期檢查等工作。
任職要求:本科及以上,有在GLP機(jī)構(gòu)計(jì)算機(jī)相關(guān)工作經(jīng)驗(yàn)優(yōu)先考慮。
郵箱地址:renliziyuan@gpri.com.cn
聯(lián)系電話(huà):020-66284063
聯(lián)系人:葉小姐
2024-01-31
崗位職責(zé):
1、組織開(kāi)展新藥研發(fā)、臨床前及臨床生物樣本檢測(cè)項(xiàng)目工作;
2、根據(jù)標(biāo)準(zhǔn)及相關(guān)要求書(shū)寫(xiě)實(shí)驗(yàn)方案和總結(jié)報(bào)告;
3、使用液質(zhì)聯(lián)用儀等分析儀器進(jìn)行定性分析或含量測(cè)定,分析數(shù)據(jù)并對(duì)儀器進(jìn)行常規(guī)維護(hù)。
任職要求:
1、熟悉生物分析基本流程,具備優(yōu)秀的實(shí)驗(yàn)技能,熟練操作液質(zhì)聯(lián)用儀;
2、應(yīng)屆畢業(yè)生或一年以上相關(guān)工作經(jīng)驗(yàn)均可。
郵箱地址:renliziyuan@gpri.com.cn
聯(lián)系電話(huà):020-66284063
聯(lián)系人:葉小姐
2024-01-31
崗位職責(zé):
1. 監(jiān)控中心Beagle犬的的飼養(yǎng)管理及獸醫(yī)日常護(hù)理;
2. 負(fù)責(zé)Beagle犬的疾病的預(yù)防、監(jiān)測(cè)、診斷和處置工作;
3. 負(fù)責(zé)Beagle犬的質(zhì)量檢測(cè);
4. 負(fù)責(zé)生產(chǎn)繁育設(shè)施的管理;
5. 協(xié)助Beagle犬的銷(xiāo)售出庫(kù)等相關(guān)工作。
任職要求:
1、本科及以上學(xué)歷,動(dòng)物醫(yī)學(xué)、臨床獸醫(yī)學(xué)專(zhuān)業(yè)
2、有寵物醫(yī)院工作經(jīng)歷者優(yōu)先考慮
郵箱地址:renliziyuan@gpri.com.cn
聯(lián)系電話(huà):020-66284063
聯(lián)系人:葉小姐
2024-01-31
崗位職責(zé):
1)負(fù)責(zé)不同生長(zhǎng)階段犬只營(yíng)養(yǎng)需求研究
2)負(fù)責(zé)犬飼料配方研究
3)負(fù)責(zé)繁殖性能營(yíng)養(yǎng)方面的研究,配種前-妊娠中的體況控制
4)負(fù)責(zé)項(xiàng)目申請(qǐng)、實(shí)施與驗(yàn)收等
5)參與資源庫(kù)日??蒲泄ぷ?br/>任職要求:
1)學(xué)歷:研究生
2)專(zhuān)業(yè):動(dòng)物營(yíng)養(yǎng)與飼料科學(xué)
3)工作年限:不限
4)具有從事飼料配方工作經(jīng)歷優(yōu)先
5)具有飼料營(yíng)養(yǎng)對(duì)畜禽生長(zhǎng)、繁殖研究經(jīng)歷者優(yōu)先。
郵箱地址:renliziyuan@gpri.com.cn
聯(lián)系電話(huà):020-66284063
聯(lián)系人:葉小姐
2024-01-31
崗位職責(zé):
1)負(fù)責(zé)犬神經(jīng)退行性疾病、精神疾病表型評(píng)價(jià)平臺(tái)搭建與研究工作;
2)犬認(rèn)知與行為評(píng)價(jià);
3)負(fù)責(zé)項(xiàng)目申請(qǐng)、實(shí)施與驗(yàn)收等
4)參與資源庫(kù)日??蒲泄ぷ?br/>任職要求:
1)學(xué)歷:研究生
2)專(zhuān)業(yè):神經(jīng)生物學(xué)
郵箱地址:renliziyuan@gpri.com.cn
聯(lián)系電話(huà):020-66284063
聯(lián)系人:葉小姐
2024-01-31
崗位職責(zé):
1)負(fù)責(zé)研究種群遺傳質(zhì)量監(jiān)測(cè)、遺傳育種等
2)協(xié)助種犬選育、系譜管理等工作
3)負(fù)責(zé)項(xiàng)目申請(qǐng)、實(shí)施與驗(yàn)收等
4)參與資源庫(kù)日常科研工作
任職要求:
1)學(xué)歷:研究生
2)專(zhuān)業(yè):動(dòng)物遺傳育種
3)工作年限:不限
4)英語(yǔ)等級(jí):英語(yǔ)六級(jí)
5)掌握生物信息學(xué)、分子育種、數(shù)量遺傳學(xué)技術(shù)
6)有育種經(jīng)歷
郵箱地址:renliziyuan@gpri.com.cn
聯(lián)系電話(huà):020-66284063
聯(lián)系人:葉小姐
郵箱地址:gyzy_rl@126.com
聯(lián)系電話(huà):020-66284063
2024-01-31
Company profile
Company profile
Guangzhou General Pharmaceutical Research Institute Co.,Ltd
Guangzhou General Pharmaceutical Research Institute Co.,Ltd
Guangzhou General Pharmaceutical Research Institute Co.,Ltd. (hereinafter referred to as the “Research Institute”) was formerly known as Guangzhou Pharmaceutical Industry Research Institute. It was established in 1972 and was originally a comprehensive medical research institution of Guangzhou Science and Technology Bureau. In 2000, it entered the whole system. Guangyao Group, in July 2015, the entire equity was injected into Guangyao Baiyunshan Group. After more than 40 years of development, the Research Institute has become a new research and development institution with complete disciplines, talents, outstanding features, strong innovation capabilities and integrated industrialization in South China. It is also the first batch of new R&D institutions in Guangdong Province and Guangdong Province Science and Technology Services. Top 100 enterprises, Guangdong Province honest demonstration enterprises, Guangzhou Science and Technology Innovation Little Giant Enterprise, Guangzhou Pharmaceutical Industry Intellectual Property Advantage Enterprise, Guangzhou Science and Technology Service Industry Model Enterprise.
READ MOREResearch and development Center
Research and development Center
The Drug Non-Clinical Evaluation Research Center (National Key Laboratory of New Drug Safety Evaluation of Guangzhou) is the technical platform for drug R&D and safety evaluation established by the National Pharmaceutical Research Institute of Guangzhou Pharmaceutical Industry Co., Ltd. (hereinafter referred to as the “Center”). The center has a long history of GLP qualifications. As early as 1997, it began to set up a GLP laboratory--"National Ninth Five-Year Plan Project----------------------------------------------------- It became one of the first research institutes for the evaluation of new drug safety in the "1035 Project" in China; in September 2004, it passed the GLP certification of CFDA and became the first institution to pass GLP certification in South China; in 2010, it passed the international AAALAC certification, which is the South China region. The first institution to pass AAALAC certification is the first institution in South China to receive both
The National Canine Experimental Animal Seed Center (hereinafter referred to as the “Center”) is the only national canine experimental animal seed center approved by the Ministry of Science and Technology in June 2010 (Guo Ke Fa Cai [2010] No. 267), which is affiliated to Guangzhou Medical Research Institute. Hospital Co., Ltd. Founded in 1983, the center is a professional research institute for experimental Beagle dog resources with a long history, pure source, standardized management and leading level. It has been committed to the preservation, breeding, research and development of germplasm resources, and is a domestic experimental animal breeding institution. , research institutes, new drug research and development institutions and customs provide high-quality breeding dogs, research dogs, teaching dogs and quarantine dogs and other series of public welfare services.
Based on the GLP management system, the biological sample testing center is a third-party public service platform for providing standardized biological sample testing services. Center based on perfect quality management system and the GLP research for many years, equipped with complete facilities and international advanced equipment, USES the industry recognized biological analysis in laboratory information management system of Watson LIMS ? to manage laboratory, its internal management, experiment method to form and content completely accords with the specification of GLP and 21 CFR PART11, provides a safe and reliable data for laboratory management; The center is dedicated to the analysis and testing of biological samples. It can develop, verify and apply a variety of analytical methods for testing, and provide professional technical services from a scientific and regulatory perspective.
Drug screening and research and development center has been committed to technology research, chiral synthesis and separation, and all kinds of controlled release technology research and industrialization of research, have many years of research, tracking progress abroad, successfully developed a number of three kinds of new chemical API, and achieved a lot slow controlled release and other preparations of the new drug certificate and production approval, has the first-class national new drug research and the ability of quality standards, quality first in a series of dozens of agents and the quality of scientific research subject, accumulated a wealth of experience.
Technical service
▲ Carry out new drug research and development for enterprises, including innovative drugs, generic drugs, high-end preparations, secondary development of famous and excellent Chinese patent drugs and other businesses. ▲ Provide safety evaluation and pharmacodynamic evaluation services in line with domestic and foreign standards and application requirements, including single multiple administration toxicity test, reproductive toxicity test, genetic toxicity test, local toxicity test, immunogenicity test, safety pharmacological test, toxicokinetic test, pharmacodynamic test, pharmacodynamic evaluation, etc. ▲ It has the only third-party public service platform for biological sample testing in south China with GLP qualification and quality assessment by the ministry of health, which can provide high-level biological sample testing technology services in line with domestic and international application requirements, and its quality system is in line with international standards. ▲ It has t
READ MOREQualification certification
GLP certification, international AAALAC accredited Beagle Dog and Monkey Research Center (DMRC), National Key Laboratory of New Drug Safety Evaluation Research, National Canine Experimental Animal Seed Center, South China New Drug Safety Evaluation Center
READ MORE